Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Type I interferon regulation by USP18 is a key vulnerability in cancer

Title: Type I interferon regulation by USP18 is a key vulnerability in cancer
Authors: Veronica Jové; Heather Wheeler; Chiachin Wilson Lee; David R. Healy; Kymberly Levine; Erik C. Ralph; Masaya Yamaguchi; Ziyue Karen Jiang; Edward Cabral; Yingrong Xu; Jeffrey Stock; Bing Yang; Anand Giddabasappa; Paula Loria; Agustin Casimiro-Garcia; Benedikt M. Kessler; Adán Pinto-Fernández; Véronique Frattini; Paul D. Wes; Feng Wang
Source: iScience, Vol 27, Iss 4, Pp 109593- (2024)
Publisher Information: Elsevier
Publication Year: 2024
Collection: Directory of Open Access Journals: DOAJ Articles
Subject Terms: Immunity; Immune response; Cell biology; Cancer; Science
Description: Summary: Precise regulation of Type I interferon signaling is crucial for combating infection and cancer while avoiding autoimmunity. Type I interferon signaling is negatively regulated by USP18. USP18 cleaves ISG15, an interferon-induced ubiquitin-like modification, via its canonical catalytic function, and inhibits Type I interferon receptor activity through its scaffold role. USP18 loss-of-function dramatically impacts immune regulation, pathogen susceptibility, and tumor growth. However, prior studies have reached conflicting conclusions regarding the relative importance of catalytic versus scaffold function. Here, we develop biochemical and cellular methods to systematically define the physiological role of USP18. By comparing a patient-derived mutation impairing scaffold function (I60N) to a mutation disrupting catalytic activity (C64S), we demonstrate that scaffold function is critical for cancer cell vulnerability to Type I interferon. Surprisingly, we discovered that human USP18 exhibits minimal catalytic activity, in stark contrast to mouse USP18. These findings resolve human USP18's mechanism-of-action and enable USP18-targeted therapeutics.
Document Type: article in journal/newspaper
Language: English
Relation: http://www.sciencedirect.com/science/article/pii/S2589004224008150; https://doaj.org/toc/2589-0042; https://doaj.org/article/9891ba2dcc8a4ca097d1e8e73e654873
DOI: 10.1016/j.isci.2024.109593
Availability: https://doi.org/10.1016/j.isci.2024.109593; https://doaj.org/article/9891ba2dcc8a4ca097d1e8e73e654873
Accession Number: edsbas.DA07A7F3
Database: BASE